M&T BANK CORP - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$357,000
-5.8%
12,8180.0%0.00%0.0%
Q2 2021$379,000
+5.9%
12,8180.0%0.00%0.0%
Q1 2021$358,000
+11.9%
12,818
+13.4%
0.00%
+100.0%
Q4 2020$320,000
+12.7%
11,3060.0%0.00%0.0%
Q3 2020$284,000
+2.9%
11,3060.0%0.00%0.0%
Q2 2020$276,000
+65.3%
11,306
+0.4%
0.00%0.0%
Q1 2020$167,000
-25.4%
11,257
-18.4%
0.00%0.0%
Q4 2019$224,000
+25.1%
13,7940.0%0.00%0.0%
Q3 2019$179,000
+17.0%
13,794
+16.6%
0.00%0.0%
Q2 2019$153,00011,8340.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders